Differences in Efficacy and Cytokine Profiles following Echinocandin or Liposomal Amphotericin B Monotherapy or Combination Therapy for Murine Pulmonary or Systemic Aspergillus flavus Infections

Given the recent increase in aspergillosis caused by species other than Aspergillus fumigatus, micafungin, caspofungin, and liposomal amphotericin B (L-AmBi) were investigated as monotherapy or combination therapy for murine systemic or pulmonary Aspergillus flavus infection. Treatment for 3 or 6 da...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Olson, J. A., Schwartz, J., Hahka, D., George, A., Proffitt, R. T., Adler-Moore, J. P.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2012
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3256087/
https://ncbi.nlm.nih.gov/pubmed/21968353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00607-11
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars